Combination of shikonin with paclitaxel overcomes multidrug resistance in human ovarian carcinoma cells in a P-gp-independent manner through enhanced ROS generation

• Main Authors: Zhu Wang (Author), Jianhua Yin (Author), Mingxing Li (Author), Jing Shen (Author), Zhangang Xiao (Author), Yueshui Zhao (Author), Chengliang Huang (Author), Hanyu Zhang (Author), Zhuo Zhang (Author), Chi Hin Cho (Author), Xu Wu (Author)
• Format: Book
• Published: BMC, 2019-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Shikonin (SKN), a naphthoquinone compound, is isolated from Chinese herbal medicine Lithospermum root and has been studied as an anticancer drug candidate in human tumor models. This study is designed to investigate whether SKN can sensitize the therapeutic effect of paclitaxel (...